CUAMC
IOVA icon

China Universal Asset Management Company’s Iovance Biotherapeutics IOVA Stock Holding History

China Universal Asset Management Company’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Sell
71,061
-2,045
-3% -$7.77K 0.02% 325
2026
Q1 		$257K Buy
73,106
+8,420
+13% +$26.9K 0.02% 331
2025
Q4 		$177K Buy
64,686
+1,258
+2% +$2.91K 0.01% 358
2025
Q3 		$138K Sell
63,428
-3,641
-5% -$8.6K 0.01% 360
2025
Q2 		$115K Buy
67,069
+1,303
+2% +$3.24K 0.01% 353
2025
Q1 		$219K Buy
65,766
+1,141
+2% +$5.88K 0.02% 307
2024
Q4 		$478K Buy
64,625
+6,249
+11% +$57.9K 0.04% 255
2024
Q3 		$548K Buy
58,376
+25,500
+78% +$242K 0.06% 204
2024
Q2 		$264K Sell
32,876
-20,832
-39% -$223K 0.04% 203
2024
Q1 		$796K Buy
53,708
+24,106
+81% +$281K 0.1% 143
2023
Q4 		$241K Buy
29,602
+23,246
+366% +$122K 0.05% 189
2023
Q3 		$28.9K Buy
6,356
+3,414
+116% +$22.3K 0.01% 270
2023
Q2 		$20.7K Sell
2,942
-96
-3% -$687 0.01% 266
2023
Q1 		$18.6K Buy
3,038
+1,435
+90% +$9.9K 0.01% 226
2022
Q4 		$10.2K Buy
1,603
+125
+8% +$976 ﹤0.01% 225
2022
Q3 		$14K Buy
+1,478
New +$17K 0.01% 178

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

China Universal Asset Management Company's IOVA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Iovance Biotherapeutics (IOVA) stake by 2.8% in Q2 2026, selling an estimated $7.77K and leaving 71,061 shares worth $296K. The position accounts for 0.02% of the portfolio, ranked #325.

China Universal Asset Management Company first reported a position in IOVA in Q3 2022 and has held it in 16 quarters since. The position peaked at $796K in Q1 2024. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • China Universal Asset Management Company held 71,061 shares of Iovance Biotherapeutics worth $296K as of Q2 2026.
  • China Universal Asset Management Company sold 2,045 Iovance Biotherapeutics shares in Q2 2026, an estimated $7.77K.
  • Iovance Biotherapeutics made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #325 holding.
  • China Universal Asset Management Company first reported a position in Iovance Biotherapeutics in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Iovance Biotherapeutics position peaked at $796K in Q1 2024.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.